133 related articles for article (PubMed ID: 33819507)
1. Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.
Kamikaseda Y; Uruno T; Kunimura K; Harada A; Saiki K; Oisaki K; Sakata D; Nakahara T; Kido-Nakahara M; Kanai M; Nakamura S; Ohkawa Y; Furue M; Fukui Y
J Allergy Clin Immunol; 2021 Aug; 148(2):633-638. PubMed ID: 33819507
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction.
Yamamura K; Uruno T; Shiraishi A; Tanaka Y; Ushijima M; Nakahara T; Watanabe M; Kido-Nakahara M; Tsuge I; Furue M; Fukui Y
Nat Commun; 2017 Jan; 8():13946. PubMed ID: 28067314
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
4. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B.
Lee YS; Han SB; Ham HJ; Park JH; Lee JS; Hwang DY; Jung YS; Yoon DY; Hong JT
J Allergy Clin Immunol; 2020 Jul; 146(1):156-168. PubMed ID: 31931018
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
Furue M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.
Kunimura K; Fukui Y
Int Immunol; 2021 Nov; 33(12):731-736. PubMed ID: 34491348
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.
Furue M; Yamamura K; Kido-Nakahara M; Nakahara T; Fukui Y
Allergy; 2018 Jan; 73(1):29-36. PubMed ID: 28670717
[TBL] [Abstract][Full Text] [Related]
8. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
Nakashima C; Otsuka A; Kabashima K
Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
[TBL] [Abstract][Full Text] [Related]
10. NFAT1 and JunB cooperatively regulate IL-31 gene expression in CD4+ T cells in health and disease.
Hwang JS; Kim GC; Park E; Kim JE; Chae CS; Hwang W; Lee C; Hwang SM; Wang HS; Jun CD; Rudra D; Im SH
J Immunol; 2015 Feb; 194(4):1963-74. PubMed ID: 25595785
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
12. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
13. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
15. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M.
Kanda N; Watanabe S
Immunobiology; 2012 Apr; 217(4):436-45. PubMed ID: 22137028
[TBL] [Abstract][Full Text] [Related]
16. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Lin CC; Bradstreet TR; Schwarzkopf EA; Jarjour NN; Chou C; Archambault AS; Sim J; Zinselmeyer BH; Carrero JA; Wu GF; Taneja R; Artyomov MN; Russell JH; Edelson BT
J Exp Med; 2016 Feb; 213(2):251-71. PubMed ID: 26834156
[TBL] [Abstract][Full Text] [Related]
17. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
18. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Brunner PM; Pavel AB; Khattri S; Leonard A; Malik K; Rose S; Jim On S; Vekaria AS; Traidl-Hoffmann C; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Fuentes-Duculan J; Li X; Zheng X; Estrada Y; Garcet S; Wen HC; Gonzalez J; Coats I; Cueto I; Neumann AU; Lebwohl MG; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jan; 143(1):142-154. PubMed ID: 30121291
[TBL] [Abstract][Full Text] [Related]
19. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.
Nograles KE; Zaba LC; Shemer A; Fuentes-Duculan J; Cardinale I; Kikuchi T; Ramon M; Bergman R; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2009 Jun; 123(6):1244-52.e2. PubMed ID: 19439349
[TBL] [Abstract][Full Text] [Related]
20. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
